Enrico Novelli, MD
Internal Medicine · Pittsburgh, PANPI 1033243639
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $137,616 of the $175,959 with a category attached, or 78.2%. Novo Nordisk Health Care AG accounts for 85.4% of it on its own, with 5 other manufacturers making up the rest. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $4291.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk Health Care AG$150K
- Novo Nordisk$13K
- Shield Therapeutics Inc$6K
- Chiesi USA, Inc.$4K
- Novartis$2K
- Vertex$42
Across 62 payments — averaging $3564.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Agios Pharmaceuticals, Inc.$216K
- Novartis$5K
What the payments were for
- Consulting fees$137,61678%
- Speaking & faculty fees$10,0706%
- Travel & lodging$26,53715%
- Food & beverage$1,7361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk Health Care AG | 28 | $150,295 |
| Novo Nordisk | 4 | $13,125 |
| Shield Therapeutics Inc | 4 | $6,294 |
| Chiesi USA, Inc. | 1 | $3,915 |
| Novartis | 3 | $2,288 |
| Vertex | 1 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$175,959 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 42 | $31,963 |
| Enoxaparin Sodium | 15 | $6,551 |
| Hydromorphone Hcl | 31 | $1,501 |
| Oxycodone Hcl | 23 | $422 |
| Warfarin Sodium | 18 | $316 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $192 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Pittsburgh
- Donald MiddletonPittsburgh$258K
- Sandra SobelPittsburgh$176K
- Abdullah AzharPittsburgh$120K
- Bassel SayeghPittsburgh$77K
- Liza VillaruzPittsburgh$53K
- David MillerPittsburgh$50K
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.